Effect of adenosine: Difference between revisions
Jump to navigation
Jump to search
m (Created page with '600px|Effect van adenosine bij een tachycardie<cite>ACC</cite> == Referenties == <biblio> #ACC pmid=14557344 </biblio>') |
mNo edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
[[File: | [[File:Svt_adenosine_en.png|800px|Effect of adenosine during tachycardia<cite>ACC</cite>]] | ||
== | == Reference == | ||
<biblio> | <biblio> | ||
#ACC pmid=14557344 | #ACC pmid=14557344 | ||
</biblio> | </biblio> | ||
Latest revision as of 10:46, 11 November 2009
![Effect of adenosine during tachycardia[1]](/index.php?title=File:Svt_adenosine_en.png)
Reference
- Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW Jr, Stevenson WG, Tomaselli GF, Antman EM, Smith SC Jr, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO Jr, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ, American College of Cardiology, American Heart Association Task Force on Practice Guidelines, and European Society of Cardiology Committee for Practice Guidelines. Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation. 2003 Oct 14;108(15):1871-909. DOI:10.1161/01.CIR.0000091380.04100.84 |